In the next issue of Pharma Technology Focus, we explore the future of sustainability in the pharma industry, and find out the potential of synthetic DNA sequencing in medicine.
Also, we take a look at the state of cell and gene therapy trials in the UK, examine the debate around treatment of chronic Lyme disease, and explore the obstacles hindering opioid access in low-income countries.
Plus, we find out how the United Parcel Service is working to improve the tracking of medical packages, investigate whether the push to meet end-of-year drug approval deadlines is putting patients at risk, and examine what went wrong for Proteus Digital Health’s smart pill.
Editor | Eloise McLennan
Group Editor | Susanne Hauner
Commissioning Editor | Daniel Garrun
Writers | Allie Nawrat, Abi Millar, Chris Lo, Natalie Healey
Magazine Designer | Marzia Del Gaone
Graphic Designers | Filipe Costa, Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Petra Konyi-Kiss, Maria Gimenez, Martina Labaiova
Lead Designer | John Hammond
Digital Publishing Director | Duncan West
Sales Manager | Nimai Amin
+44 (0) 207 936 6453
For media partnership enquiries please contact our publishing assistant: Sophie Hoare
Pharma Technology focus is powered by h5mag
read past issues of pharma technology focus HERE
Copyright 2020 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.